I've been a follower of EMS for a long time although not as on top of things of late as what I usually am. I have held some pretty frustrating stocks and still hold some now but at least with EMS, there appears to be a visible endpoint to the frustration. One way or another, by the end of December (or there abouts) you will have a good idea as to whether you can look forward to a licensing/ partnering agreement or on the other hand, look to where you can invest the hollow remains of your EMS funds if the trial results are poor.
Personally, I think the trial will be successful based on previous results although this is never a given, look at BXN!
I had a buy order in at 1c not too long ago and then decided not to chance it when it when for a run recently. Nevertheless, lets hope you all have success with this stock, as it will give all frustrated biotech holders hope that it is worth it in the longterm.
Best of luck, Hammer
EMS Price at posting:
3.4¢ Sentiment: Buy Disclosure: Not Held
